Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

FRA:XIN Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,234	1,245	918.33	1,159	744.66	855.77
Cash & Short-Term Investments	1,234	1,245	918.33	1,159	744.66	855.77
Cash Growth	6.57%	35.57%	-20.75%	55.61%	-12.98%	23.94%
Accounts Receivable	1,285	1,120	949.16	970.63	870.46	518.55
Other Receivables	10.23	9.5	9.34	12.65	17.42	25.16
Receivables	1,295	1,129	958.5	983.28	887.87	543.71
Inventory	1,252	1,273	1,313	1,212	1,028	1,124
Prepaid Expenses	-	0.03	3.41	-	-	7.15
Other Current Assets	116.8	79.78	121.1	102.95	93.88	155.88
Total Current Assets	3,899	3,727	3,314	3,457	2,754	2,687
Property, Plant & Equipment	4,204	4,296	4,061	4,000	3,766	3,539
Long-Term Investments	300.65	306.42	241.37	239.18	260.2	316.62
Other Intangible Assets	561.66	565.04	494.94	474.11	466.45	449.25
Long-Term Deferred Tax Assets	15.54	24.92	23.48	15.62	15.17	23.52
Long-Term Deferred Charges	16.4	9.99	14.46	8.61	10.54	11.92
Other Long-Term Assets	96.82	90.75	136.77	69.85	59.99	65.93
Total Assets	9,094	9,020	8,286	8,265	7,332	7,093
Accounts Payable	1,295	1,159	1,178	1,090	1,066	742.9
Accrued Expenses	36.99	137.28	203.11	159.43	122.35	144.87
Short-Term Debt	513.51	580.16	283.96	118.02	269.46	200.42
Current Portion of Long-Term Debt	508.38	312.26	271.97	714.77	421.03	356.55
Current Portion of Leases	-	1.4	1.78	2.69	2.8	1.56
Current Income Taxes Payable	27.61	6.69	5.03	7.99	12.2	4.42
Current Unearned Revenue	76.03	96.84	149.14	593.26	100.4	377.79
Other Current Liabilities	525.11	502.3	393.16	472.23	507.26	552.53
Total Current Liabilities	2,982	2,796	2,486	3,158	2,502	2,381
Long-Term Debt	498.32	771.54	799.4	545.66	946.2	1,063
Long-Term Leases	1.03	1.11	1.58	2.72	6.77	23.93
Long-Term Unearned Revenue	73.36	83.25	100.67	118.37	133.97	146.5
Long-Term Deferred Tax Liabilities	120.21	122.53	99.21	66.44	65.61	69.31
Other Long-Term Liabilities	28.06	28.06	23.56	23.56	26.46	18.14
Total Liabilities	3,703	3,802	3,510	3,915	3,681	3,702
Common Stock	689.78	682.41	674.68	669.63	627.37	621.86
Additional Paid-In Capital	1,206	1,145	1,055	998.14	677.94	644.91
Retained Earnings	3,073	2,989	2,706	2,345	2,034	1,780
Comprehensive Income & Other	180.9	175.86	117.01	113.68	128.37	177.21
Total Common Equity	5,149	4,992	4,553	4,126	3,468	3,224
Minority Interest	241.37	225.91	222.65	223.29	183.2	167.5
Shareholders' Equity	5,390	5,218	4,776	4,350	3,651	3,391
Total Liabilities & Equity	9,094	9,020	8,286	8,265	7,332	7,093
Total Debt	1,521	1,666	1,359	1,384	1,646	1,645
Net Cash (Debt)	-286.81	-421.45	-440.36	-225.11	-901.58	-789.42
Net Cash Per Share	-0.41	-0.61	-0.64	-0.34	-1.44	-1.26
Filing Date Shares Outstanding	689.78	689.78	682.41	669.63	627.37	627.37
Total Common Shares Outstanding	689.78	682.41	674.68	669.63	627.37	621.86
Working Capital	916.43	931.23	828.33	298.47	252.08	305.83
Book Value Per Share	7.46	7.31	6.75	6.16	5.53	5.18
Tangible Book Value	4,587	4,427	4,058	3,652	3,001	2,775
Tangible Book Value Per Share	6.65	6.49	6.01	5.45	4.78	4.46
Buildings	-	2,411	2,271	2,244	2,078	1,948
Machinery	-	5,128	4,703	4,468	4,011	3,690
Construction In Progress	-	781.1	730.55	545.89	562.96	416.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.